FELICETTI, TOMMASO
 Distribuzione geografica
Continente #
NA - Nord America 664
EU - Europa 513
AS - Asia 160
AF - Africa 1
SA - Sud America 1
Totale 1.339
Nazione #
US - Stati Uniti d'America 664
IT - Italia 209
IE - Irlanda 148
HK - Hong Kong 98
BE - Belgio 32
DE - Germania 29
SE - Svezia 27
VN - Vietnam 26
CN - Cina 20
RU - Federazione Russa 20
FI - Finlandia 9
GB - Regno Unito 8
RO - Romania 8
UA - Ucraina 7
CH - Svizzera 4
FR - Francia 4
KR - Corea 4
JP - Giappone 3
NL - Olanda 3
SG - Singapore 3
AT - Austria 2
UZ - Uzbekistan 2
BG - Bulgaria 1
BR - Brasile 1
CI - Costa d'Avorio 1
ID - Indonesia 1
IR - Iran 1
LB - Libano 1
PK - Pakistan 1
PL - Polonia 1
PT - Portogallo 1
Totale 1.339
Città #
Chandler 221
Dublin 148
Perugia 98
Hong Kong 95
San Mateo 44
Altamura 39
Brussels 32
Medford 29
Princeton 29
Lawrence 27
Dong Ket 25
Redmond 21
Wilmington 20
Spoleto 17
Redwood City 15
Andover 10
Des Moines 9
Fremont 9
Los Angeles 9
San Giustino 9
Ann Arbor 8
West Jordan 8
Bucharest 7
New York 7
Beijing 6
Helsinki 6
Saint Petersburg 6
Houston 5
Norwalk 5
Hanover 4
Xian 4
Ashburn 3
Bologna 3
Foligno 3
Milan 3
Vigodarzere 3
Boydton 2
Campegine 2
Chongqing 2
Dallas 2
Dearborn 2
Den Haag 2
Genova 2
Jacksonville 2
Jinan 2
Moscow 2
Padova 2
Rome 2
San Gemini 2
Seoul 2
Shanghai 2
Umbertide 2
Abidjan 1
Absecon 1
Amsterdam 1
Ardabil 1
Bastia umbra 1
Boston 1
Buffalo 1
Böblingen 1
Castello di Godego 1
Fairfield 1
Falkenstein 1
Falls Church 1
Frankfurt Am Main 1
Hangzhou 1
Hanoi 1
Horia 1
Ispica 1
Jakarta 1
Kagoya 1
Kunming 1
Lisbon 1
London 1
Monmouth Junction 1
Nanchang 1
Pasadena 1
Philadelphia 1
Phoenix 1
San Jose 1
San Paolo di Civitate 1
Seattle 1
Singapore 1
Tokyo 1
Vienna 1
Zurich 1
Totale 1.053
Nome #
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient One-step Synthesis and Functionalization as Influenza Polymerase PA-PB1 Interaction Disruptors 87
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction 69
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors 63
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 62
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation 62
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors 61
Deciphering the molecular recognition mechanism of multidrug resistance staphylococcus aureus nora efflux pump using a supervised molecular dynamics approach 59
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position 56
Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions 55
Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors 54
Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues 52
C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors 52
Design and synthesis of WM5 analogues as HIV-1 TAR RNA binders. 50
Synthesis and Characterization of 1,2,4-Triazolo[1,5-a]pyrimidine-2-carboxamide-based Compounds Targeting the PA-PB1 Interface of Influenza A Virus Polymerase. 49
Biofunctionalization of Poly(lactide-co-glycolic acid) Using Potent NorA Efflux Pump Inhibitors Immobilized on Nanometric Alpha-Zirconium Phosphate to Reduce Biofilm Formation 45
Ethidium bromide exposure unmasks an antibiotic efflux system in Rhodococcus equi 43
Investigation on the effect of known potent S. aureus NorA efflux pump inhibitors on the staphylococcal biofilm formation 42
Broad-Spectrum Flavivirus Inhibitors: a Medicinal Chemistry Point of View 42
New C-6 functionalized quinoline NorA inhibitors strongly synergize with ciprofloxacin against planktonic and biofilm growing resistant Staphylococcus aureus strains 36
Modifications on C6 and C7 Positions of 3-Phenylquinolone Efflux Pump Inhibitors Led to Potent and Safe Antimycobacterial Treatment Adjuvants 36
Tumour cell population growth inhibition and cell death induction of functionalized 6-aminoquinolone derivatives 35
Modulating microRNA Processing: Enoxacin, the Progenitor of a New Class of Drugs 35
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search 34
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium 32
An overview on small molecules acting as broad-spectrum agents for yellow fever infection 30
Building up efflux-mediated antimicrobial resistance in Staphylococcus pseudintermedius 25
Sustainable, three-component, one-pot procedure to obtain active anti-flavivirus agents 24
Targeting miRNA dysregulation with small molecules: The case of enoxacin 24
Microbial efflux pump inhibitors: A journey around quinoline and indole derivatives 23
Triazolopyrimidine nuclei: privileged scaffolds for developing antiviral agents with a proper pharmacokinetic profile. 21
Protein-protein interactions by influenza polymerase subunits as drug targets 20
Drug efflux transporters in Staphylococcus pseudintermedius: in silico prediction and characterization of resistance 14
Discovery of 2-Phenylquinolines with Broad-Spectrum Anti-coronavirus Activity 13
EVALUATION OF DRUG EFFLUX ACTIVITY IN ANTIMICROBIAL RESISTANT STAPHYLOCOCCUS PSEUDINTERMEDIUS CLINICAL ISOLATES 13
Inhibition of Staphylococcus pseudintermedius Efflux Pumps by Using Staphylococcus aureus NorA Efflux Pump Inhibitors 12
Functionalized sulfonyl anthranilic acid derivatives inhibit replication of all the four dengue serotypes 12
Optimized Inhibitors of MDM2 via an Attempted Protein-Templated Reductive Amination 12
Fighting Antimicrobial Resistance: Insights on How the Staphylococcus aureus NorA Efflux Pump Recognizes 2-Phenylquinoline Inhibitors by Supervised Molecular Dynamics (SuMD) and Molecular Docking Simulations 11
Virucidal Activity of the Pyridobenzothiazolone Derivative HeE1-17Y against Enveloped RNA Viruses 8
Switching the three-component Biginelli-like reaction conditions for the regioselective synthesis of new 2-amino[1,2,4]triazolo[1,5-a]pyrimidines 5
Totale 1.478
Categoria #
all - tutte 6.398
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.398


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20195 0 0 0 0 0 0 0 0 0 0 0 5
2019/202049 1 3 2 0 1 5 13 2 4 15 2 1
2020/2021191 0 16 5 11 39 16 51 6 17 3 1 26
2021/2022311 10 35 6 11 13 2 44 69 29 16 30 46
2022/2023617 30 128 7 67 45 72 0 28 191 10 29 10
2023/2024255 20 54 16 5 8 12 93 7 14 26 0 0
Totale 1.478